Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.98 USD | +3.47% | +7.58% | -29.22% |
May. 02 | CUREVAC : A missed opportunity | |
Apr. 26 | UBS Cuts CureVac Price Target to $14 From $18, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.22% | 667M | |
+23.37% | 47.02B | |
+49.90% | 41.86B | |
-0.94% | 41.76B | |
-4.27% | 28.8B | |
+11.29% | 26.05B | |
-20.92% | 19.15B | |
+3.20% | 12.55B | |
+30.23% | 12.34B | |
-2.67% | 11.82B |
- Stock Market
- Equities
- CVAC Stock
- News CureVac N.V.
- CureVac Begins Early Stage Portion of Investigational Vaccine Trial